Markus J. Cappel, Chief Business Officer & Treasurer at ChemoCentryx, Inc. (CCXI), sold 232,912 shares at $36.71 ($8.7M) on 2020-01-13, disclosed to the SEC on 2020-01-15.
Seasonal sale ($8.7M) by Chief Business Officer & Treasurer — this insider has traded CCXI in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.71 | 43,556 | $1.6M | 18.4% |
| 2 | $36.71 | 43,556 | $1.6M | 18.4% |
| 3 | $37.48 | 42,755 | $1.6M | 18.5% |
| 4 | $37.48 | 42,755 | $1.6M | 18.5% |
| 5 | $37.78 | 30,145 | $1.1M | 13.1% |
| 6 | $37.78 | 30,145 |
| $1.1M |
| 13.1% |
| Total | $37.27 avg | 232,912 | $8.7M | 100% |
| Filing → |
| CCXI | SELL | 2021-02-11 | $49K | — | Filing → |
| CCXI | SELL | 2021-02-08 | $1.2M | — | Filing → |
| CCXI | SELL | 2021-01-27 | $184K | — | Filing → |